Anthem Biosciences Shareholding Pattern
- Market cap
- ₹49,765 crore
- P/E
- 86.4
- P/B
- 16.36
- ROE
- 21.7%
- Dividend yield
- 0.23%
As of 30-JUN-2026, promoters held 71.42% of Anthem Biosciences (-3.26 pp from 31-MAR-2026), foreign institutional investors 2.58%, domestic institutions 13.48% and the public 12.53%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Anthem Biosciences shareholding pattern — frequently asked questions
What is the promoter holding in Anthem Biosciences?
Promoters held 71.42% of Anthem Biosciences as of 30-JUN-2026, down 3.26 pp from 74.68% in 31-MAR-2026.
How much do FIIs hold in Anthem Biosciences?
Foreign institutional investors held 2.58% of Anthem Biosciences as of 30-JUN-2026, a change of +1.30 pp from the previous quarter.
How much do domestic institutions hold in Anthem Biosciences?
Domestic institutional investors, including mutual funds and insurers, held 13.48% of Anthem Biosciences as of 30-JUN-2026 (+1.93 pp from the previous quarter).
Who owns Anthem Biosciences?
As of 30-JUN-2026, Anthem Biosciences' shareholders were promoters (71.42%), foreign institutional investors 2.58%, domestic institutions 13.48% and the public 12.53%, as filed with the stock exchanges.
Same Data For Peers
- Sun Pharmaceutical Industries Limited shareholding pattern
- Divi's Laboratories Limited shareholding pattern
- Torrent Pharmaceuticals Limited shareholding pattern
- Zydus Lifesciences Limited shareholding pattern
- Apollo Hospitals Enterprise Limited shareholding pattern
- Laurus Labs Limited shareholding pattern
Trade Anthem Biosciences With ATS
Track ANTHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.